TCT
GSK icon

TIAA CREF Trust’s GSK GSK Stock Holding History

TIAA CREF Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.49M Buy
28,178
+1,365
+5% +$69.2K 0.01% 246
2016
Q4 		$1.29M Sell
26,813
-1,764
-6% -$87.1K 0.01% 248
2016
Q3 		$1.54M Sell
28,577
-1,178
-4% -$64.6K 0.01% 223
2016
Q2 		$1.61M Sell
29,755
-1,865
-6% -$98.3K 0.01% 210
2016
Q1 		$1.6M Sell
31,620
-1,071
-3% -$53.3K 0.02% 206
2015
Q4 		$1.65M Buy
32,691
+1,557
+5% +$79.4K 0.02% 199
2015
Q3 		$1.5M Sell
31,134
-72
-0.2% -$3.75K 0.02% 195
2015
Q2 		$1.62M Buy
31,206
+2,205
+8% +$124K 0.02% 190
2015
Q1 		$1.67M Buy
29,001
+202
+0.7% +$11.6K 0.02% 190
2014
Q4 		$1.54M Buy
28,799
+212
+0.7% +$11.9K 0.02% 194
2014
Q3 		$1.64M Sell
28,587
-1,727
-6% -$106K 0.02% 185
2014
Q2 		$2.03M Buy
30,314
+104
+0.3% +$7.04K 0.03% 174
2014
Q1 		$2.02M Buy
30,210
+2,046
+7% +$138K 0.03% 163
2013
Q4 		$1.88M Buy
28,164
+14,882
+112% +$965K 0.03% 168
2013
Q3 		$833K Sell
13,282
-644
-5% -$41.5K 0.02% 207
2013
Q2 		$870K Buy
+13,926
New +$884K 0.02% 195

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TIAA CREF Trust's GSK Position: Q1 2017 in Review

TIAA CREF Trust increased its GSK (GSK) stake by 5.1% in Q1 2017, buying an estimated $69.2K and bringing the position to 28,178 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #246.

TIAA CREF Trust first reported a position in GSK in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.03M in Q2 2014. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • TIAA CREF Trust held 28,178 shares of GSK worth $1.49M as of Q1 2017.
  • TIAA CREF Trust bought 1,365 GSK shares in Q1 2017, an estimated $69.2K.
  • GSK made up 0.01% of TIAA CREF Trust's portfolio in Q1 2017, its #246 holding.
  • TIAA CREF Trust first reported a position in GSK in Q2 2013 and has held it in 16 quarters since.
  • TIAA CREF Trust's GSK position peaked at $2.03M in Q2 2014.
  • 786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.